PortfoliosLab logoPortfoliosLab logo
BEAM vs. TWST
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BEAM vs. TWST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Beam Therapeutics Inc. (BEAM) and Twist Bioscience Corporation (TWST). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BEAM achieves a 28.17% return, which is significantly lower than TWST's 168.51% return.


BEAM

1D
4.07%
1M
24.06%
YTD
28.17%
6M
27.26%
1Y
111.99%
3Y*
3.76%
5Y*
-16.23%
10Y*

TWST

1D
-2.73%
1M
40.61%
YTD
168.51%
6M
142.93%
1Y
145.87%
3Y*
70.18%
5Y*
-6.65%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

BEAM vs. TWST - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
BEAM
Beam Therapeutics Inc.
28.17%11.77%-8.89%-30.40%-50.92%-2.39%240.17%
TWST
Twist Bioscience Corporation
168.51%-31.74%26.07%54.81%-69.23%-45.23%428.19%

Correlation

The correlation between BEAM and TWST is 0.42, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.42

Correlation (3Y)
Calculated over the trailing 3-year period

0.49

Correlation (5Y)
Calculated over the trailing 5-year period

0.60

Correlation (All Time)
Calculated using the full available price history since Feb 6, 2020

0.55

The correlation between BEAM and TWST shifts across timeframes, from 0.42 (1 year) to 0.60 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

BEAM:

$3.67B

TWST:

$5.26B

EPS

BEAM:

-$0.63

TWST:

-$1.33

PS Ratio

BEAM:

27.72

TWST:

12.71

PB Ratio

BEAM:

3.15

TWST:

11.55

Total Revenue (TTM)

BEAM:

$132.27M

TWST:

$409.48M

Gross Profit (TTM)

BEAM:

-$84.92M

TWST:

$213.23M

EBITDA (TTM)

BEAM:

-$68.39M

TWST:

-$58.23M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BEAM vs. TWST — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BEAM
BEAM Risk / Return Rank: 8181
Overall Rank
BEAM Sharpe Ratio Rank: 8282
Sharpe Ratio Rank
BEAM Sortino Ratio Rank: 8282
Sortino Ratio Rank
BEAM Omega Ratio Rank: 7777
Omega Ratio Rank
BEAM Calmar Ratio Rank: 8383
Calmar Ratio Rank
BEAM Martin Ratio Rank: 8080
Martin Ratio Rank

TWST
TWST Risk / Return Rank: 8686
Overall Rank
TWST Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
TWST Sortino Ratio Rank: 8686
Sortino Ratio Rank
TWST Omega Ratio Rank: 8282
Omega Ratio Rank
TWST Calmar Ratio Rank: 8888
Calmar Ratio Rank
TWST Martin Ratio Rank: 8484
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BEAM vs. TWST - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Beam Therapeutics Inc. (BEAM) and Twist Bioscience Corporation (TWST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BEAMTWSTDifference
Sharpe ratioReturn per unit of total volatility

-0.70

Sortino ratioReturn per unit of downside risk

-0.35

Omega ratioGain probability vs. loss probability

1.27

1.31

-0.05

Calmar ratioReturn relative to maximum drawdown

2.95

3.84

-0.89

Martin ratioReturn relative to average drawdown

6.34

8.14

-1.80

BEAM vs. TWST - Sharpe Ratio Comparison

The current BEAM Sharpe Ratio is 1.49, which is lower than the TWST Sharpe Ratio of 2.20. The chart below compares the historical Sharpe Ratios of BEAM and TWST, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BEAM vs. TWST - Drawdown Comparison

The maximum BEAM drawdown since its inception was -89.12%, smaller than the maximum TWST drawdown of -94.48%. Use the drawdown chart below to compare losses from any high point for BEAM and TWST.


Loading charts...

Drawdown Indicators


BEAMTWSTDifference

Max Drawdown

Largest peak-to-trough decline

-89.12%

-94.48%

+5.36%

Max Drawdown (1Y)

Largest decline over 1 year

-38.15%

-38.24%

+0.09%

Max Drawdown (3Y)

Largest decline over 3 years

-67.74%

-58.97%

-8.77%

Max Drawdown (5Y)

Largest decline over 5 years

-89.12%

-91.54%

+2.42%

Current Drawdown

Current decline from peak

-73.41%

-59.05%

-14.36%

Average Drawdown

Average peak-to-trough decline

-59.93%

-58.15%

-1.78%

Ulcer Index

Depth and duration of drawdowns from previous peaks

17.72%

17.99%

-0.27%

Volatility

BEAM vs. TWST - Volatility Comparison

Beam Therapeutics Inc. (BEAM) has a higher volatility of 23.00% compared to Twist Bioscience Corporation (TWST) at 19.89%. This indicates that BEAM's price experiences larger fluctuations and is considered to be riskier than TWST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BEAMTWSTDifference

Volatility (1M)

Calculated over the trailing 1-month period

23.00%

19.89%

+3.11%

Volatility (6M)

Calculated over the trailing 6-month period

53.52%

48.60%

+4.92%

Volatility (1Y)

Calculated over the trailing 1-year period

75.50%

66.98%

+8.52%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

76.10%

75.93%

+0.17%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

80.82%

78.40%

+2.42%

Dividends

BEAM vs. TWST - Dividend Comparison

Neither BEAM nor TWST has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

BEAM vs. TWST - Financials Comparison

This section allows you to compare key financial metrics between Beam Therapeutics Inc. and Twist Bioscience Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00M300.00M350.00M202220232024202520260
110.72M
(BEAM) Total Revenue
(TWST) Total Revenue
Values in USD except per share items

Frequently Asked Questions


BEAM and TWST have a correlation of 0.42, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BEAM has higher volatility (23.00%) compared to TWST (19.89%). In terms of maximum drawdown, BEAM dropped -89.12% vs TWST's -94.48%.

TWST currently has the higher Sharpe Ratio (2.20 vs 1.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BEAM and TWST

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer